Kilter Group’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$18.4K Sell
63
-1
-2% -$329 0.01% 247
2025
Q4
$22.4K Buy
64
+12
+23% +$4.05K 0.01% 196
2025
Q3
$16.8K Buy
52
+31
+148% +$9.64K 0.01% 215
2025
Q2
$8.17K Buy
+21
New +$8.45K ﹤0.01% 300

Other funds holding ELV

Kilter Group's ELV Position: Q1 2026 in Review

Kilter Group reduced its Elevance Health (ELV) stake by 1.6% in Q1 2026, selling an estimated $329 and leaving 63 shares worth $18.4K. The position accounts for 0.01% of the portfolio, ranked #247.

Kilter Group first reported a position in ELV in Q2 2025 and has held it in 4 quarters since. The position peaked at $22.4K in Q4 2025. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • Kilter Group held 63 shares of Elevance Health worth $18.4K as of Q1 2026.
  • Kilter Group sold 1 Elevance Health share in Q1 2026, an estimated $329.
  • Elevance Health made up 0.01% of Kilter Group's portfolio in Q1 2026, its #247 holding.
  • Kilter Group first reported a position in Elevance Health in Q2 2025 and has held it in 4 quarters since.
  • Kilter Group's Elevance Health position peaked at $22.4K in Q4 2025.
  • 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on Kilter Group's 13F filing for Q1 2026, filed 14 May 2026.